This adventure in being an IPIX stockholder keeps getting

New Post Public Reply Private Reply Replies (4) Message Board
petemantx
426
This adventure in being an IPIX stockholder keeps getting crazier and crazier. This week we took the biggest step forward for the company in having a successful EOP2 meeting with the FDA for Oral Mucositis and the possibility of a Big Pharma partnership that could occur any day now which should end our financial woes, yet we see the stock hit an all time low (at least for the last 5 yrs or so). We have to contend with a wolf pack screaming bankruptcy, felonious and utter incompetence by management, and a total belief that IPIX no longer has anything of value to offer. If it was still on, this situation would be a perfect plot for the Twilight Zone.

We have seen the wolf pack mentality by both criminal and legal hedge funds trying to run the stock into the ground at its finest and most would admit it takes a strong mind and a knowledgeable background to understand what is happening and not let their workings wear us down to want to sell our shares. This is not your typical small bio investor base, thank God.

The situation makes me want to take the governmental bodies that are suppose to guard investors from this type of action and shoot them all, or shoot the Congress members that enacted laws tying their hands so they couldn't do anything to stop this. I hate politicians even more than I do attorneys, but then they are usually one and the same and that is why the country is in the ol' crapper today IMO.

Would be nice to get a partner announcement prior to Christmas to really cap off such a joyous season (Christmas is always special regardless of financial events IMO) but we may have to wait until sometime in Jan for the good news. It would be most appreciated if it could come quite early in the month, thank you.

Have tried to fight the good fight on the numbnuts board but now that seems a waste of time since you can only state the same things so often (though the wolf pack screams the same thing 24/7 for months on end). I figure if a newbie can't make up their own mind by now, tough luck for them. You can only bang your head against a wall so long until you realize all you are doing is getting a headache for no good reason.

I have all the irrelevant twits ignored on this board so it reads nicely. Will hang here pretty much all the time now. I think we have done our job as being solid longs and backing the company for years, it is now their job to get a deal done and put an end to this seemingly endless financial misery.

Of course, once the deal is announced we will all quickly forget the angst of waiting for it to finally arrive. In every conflict, there is always the one specific time and event that changes the battle and determines the outcome of the war. I believe we are now in that time and place.

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Raken Debuts Change Orders: A Game-Changer for Builds

Updated Category News Views 4

Construction Gets a Streamlined Boost with Raken's New Tool In construction, chaos often partners seamlessly with progress. But Raken is stepping in to shake things up a bit. This isn’t just another run-of-the-mill software update; this is Raken flexing its muscles in the construction tech arena. They’ve rolled out Change Orders, enhancing their project management...

Continue Reading
Ardelyx Securities Fraud Suit: Key Investor Moves

Updated Category News Views 5

Fraud Allegations: Ardelyx Under the Microscope Looks like Ardelyx has found itself neck-deep in trouble, facing a class action lawsuit over alleged securities fraud. This isn't just a storm in a teacup. We're talking about accusations of false and misleading statements tied to their commercial performance—statements that might have left investors holding the bag with...

Continue Reading
Lupin Secures FDA Nod for Key Injectable Drug

Updated Category News Views 4

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

Continue Reading
PrideStaff: 8 Years Strong on Franchise Times Top 400

Updated Category News Views 4

Where PrideStaff Stands in the Franchise Landscape Here's something the staffing world can't ignore: PrideStaff nailed it again, landing among the giants on the Franchise Times Top 400 for the eighth straight year. Sitting at number 217, this ain't just a lucky streak—this is a sustained homerun, my friends. Consistency Is Key, And They're Holding It Consider this...

Continue Reading
CME Group Unveils First Baseball Futures Market

Updated Category News Views 6

A New Pitch in the Financial Ballpark Alright, listen up: CME Group is stepping up to the plate with a game-changer. They’re rolling out the world’s first baseball futures, launching October 12, assuming regulators give the green light. Now, this isn’t just some novelty act; it’s based on the solid groundwork of their FutureSports Performance Indexes (CME FSPI),...

Continue Reading
Webull Faces Legal Scrutiny Over Chinese Ties

Updated Category News Views 5

The Unfolding Drama for Webull Shareholders When you see a ticker like NASDAQ:BULL rolling off your tongue these days, it’s not just about stock prices anymore—it's a whole saga wrapped in legal and geopolitical spice. Following the recent uproar from a House China committee report, Webull found itself thrust into the spotlight for all the wrong reasons. That report...

Continue Reading
Newfold Digital Revamps Leadership for Growth Surge

Updated Category News Views 4

Steering into New Horizons with Fresh Leadership October 2026 marks a fresh chapter for Newfold Digital, as they shuffle the deck chairs a bit and ramp up for some ambitious growth endeavors. This web and commerce tech company decided it's time to bring a few heavy hitters on board. Starting this month, watch out for Sachin Puri taking the reins as Chief Executive...

Continue Reading
Ajman Tourism Department Hits Internal Audit Milestone

Updated Category News Views 4

A Nod to Standards in Ajman's Tourism Department Folks, it's not every day you see a government department get this kind of spotlight in the internal audit arena, yet here we are. The Ajman Department of Tourism, Culture and Media has snagged Full Conformance with Internal Audit Quality Standards. That’s not just some random feather in their cap but a signal flare in...

Continue Reading
Hexaware Teams with Anthropic for Game-Changing AI Move

Updated Category News Views 4

A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...

Continue Reading
Full Sail University Bags Billboard Music School Honor

Updated Category News Views 6

Full Sail Scores a Billboard Nod — What's the Big Deal? Alright, Full Sail University just snagged a spot on Billboard Magazine's 2026 Top Music Business Schools list. That's no small fry, folks. This Florida institution has been carving out a niche in the music business education scene with a hands-on learning approach that hits the nail right on the head. The Recipe...

Continue Reading

Top 5 Most Recently Viewed Articles

Protecting the Legacy of the Tuskegee Airmen in Aviation Today

Updated Category News Views 291

Advocacy for Equity in Aviation The Organization of Black Aerospace Professionals (OBAP) stands firm in advancing diversity, equity, and inclusion (DEI) in aviation and aerospace sectors. The organization feels obligated to voice concerns over two significant issues: the repeal of Executive Order 13985, which promoted equity in federal programs, and the removal of the...

Continue Reading
TerraZero Technologies Unveils 2025 Vision with Intraverse

Updated Category News Views 313

TerraZero Technologies Highlights 2024 Developments TerraZero Technologies Inc., backed by BIGG Digital Assets Inc. (TSXV: BIGG; OTCQX: BBKCF), has made considerable progress in the digital assets realm. As 2024 wraps up, the company reflects on its substantial advancements and sets the stage for an engaging 2025, focusing on the pivotal launch of its Intraverse platform....

Continue Reading
Exploring Recent Crypto Trends: Tokens Skyrocket as BTC Rebounds

Updated Category News Views 171

Bitcoin's Remarkable Rebound Bitcoin's resurgence above $100,000 has sent ripples through the crypto market, igniting a new wave of trading enthusiasm. Investors have flocked back to various cryptocurrencies, with significant traction noted within the meme and AI sectors on the HTX exchange. Recent data shows an upsurge in trading volumes across several tokens between May...

Continue Reading
The Future of Healthcare: Understanding Consumer Trends

Updated Category News Views 198

Capturing Market Share in Health Care by Embracing Change In today's fast-paced world, the landscape of health care and life sciences is undergoing a significant transformation. Consumer demands are inspiring new opportunities to bridge gaps in care and encourage innovative entrants within the industry. As organizations look towards 2025, understanding consumer...

Continue Reading
Pomerantz Law Firm Initiates Class Action Against XPEL, Inc.

Updated Category News Views 112

Pomerantz Law Firm Launches Class Action Against XPEL, Inc. Pomerantz LLP has officially filed a class action lawsuit against XPEL, Inc. (NASDAQ: XPEL) and is inviting shareholders to get involved. Those who purchased XPEL securities during the specified Class Period are encouraged to reach out for more information. Overview of the Class Action Lawsuit This class action...

Continue Reading